angiotensin ii, des-phe(8)- has been researched along with dithiothreitol in 1 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (dithiothreitol) | Trials (dithiothreitol) | Recent Studies (post-2010) (dithiothreitol) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 7,534 | 12 | 759 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke-Wolin, T; Du, L; Li, X; Oeckler, R; Olson, S; Traganos, F; Zhao, X | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and dithiothreitol
| Article | Year |
|---|---|
Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Cattle; Cells, Cultured; Dithiothreitol; Dose-Response Relationship, Drug; Endothelium, Vascular; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptide Fragments; Pulmonary Artery; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Vasoconstriction; Vasoconstrictor Agents | 2004 |